Miyazaki I., et al. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 2004 Dec 10; 1029(1):120–3. doi:10.1016/j.brainres.2004.09.014.
Moldrich R. X., et al. Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology. 2002 Aug;43(2):189–203. doi:10.1016/S0028-3908(02)00111-9.
Ostrow L. W., Sachs F. Mechanosensation and endothelin in astrocytes — hypothetical roles in CNS pathophysiology. Brain Res Brain Res Rev. 2005 Jun; 48(3):488–508. doi:10.1016/j.brainresrev.2004.09.005.
Pellerin L. How astrocytes feed hungry neurons. Mol Neurobiol. 2005 Aug; 32(1):59–72. doi:10.1385/MN:32:1:059.
Pellerin L., Magistretti P. J. Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators. J Neurochem. 2005 Feb; 92(3):668–77. doi:10.1111/j.1471–4159.2004.02905.x.
Perchet C., et al. Attention shifts and anticipatory mechanisms in hyperactive children: an ERP study using the Posner paradigm. Biol Psychiatry. 2001 Jul 1; 50(1):44–57. doi:10.1016 /S0006-3223(00)01119-7.
Potgieter S., Vervisch J., Lagae L. Event related potentials during attention tasks in VLBW children with and without attention deficit disorder. Clin Neurophysiol. 2003 Oct; 114(10): 1841–9. doi:10.1016/S1388-2457(03)00198-6.
Ronnback L., Hansson E. On the potential role of glutamate transport in mental fatigue. J Neuroinflammation. 2004 Nov; 1(22).
Ross B. M., et al. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci. 2003 Oct; 6(5):277–81. doi:10.1080/1028 4150310001612203.
Sagvolden T., et al. A dynamic developmental theory of attention-deficit/ hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci. 2005 Jun;28(3):397–419. doi:10.1017/ S0140525X05000075.
Sanchez-Abarca L. I., Tabernero A., Medina J. M. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia. 2001 Dec; 36(3):321–9. doi:10.1002/glia.1119.
Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev. 2000 Jan; 24(1):7–12. doi:10.1016/S0149-7634(99)00060-3.
Sergeant J. A., et al. The top and the bottom of ADHD: a neuropsychological perspective. Neurosci Biobehav Rev. 2003 Nov; 27(7):583–92. doi:10.1016/j.neubiorev.2003.08.004.
Smithee J. A., et al. Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder. J Ab-norm Child Psychol. 1998 Aug; 26(4):233–45.
Sonuga-Barke E. J. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003 Nov; 27(7):593–604. doi:10.1016/j. neubiorev.2003.08.005.
Sunohara G. A., et al. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology. 1999;21:218–28. doi:10.1016/S0893-133X(99)00023-8.
Todd R. D., Botteron K. N. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry. 2001 Aug 1; 50(3):151–8. doi:10.1016/S0006-3223(01)01173-8.
Volkow N. D., et al. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res. 1998 Jul 15; 83(1):29–36. doi:10.1016 /S0925-4927(98)00025-0.
West J., et al. Response inhibition, memory and attention in boys with attention-deficit/ hyperactivity disorder. Educational Psychology. 2002; 22:533–51.
Zametkin A., et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med. 1990 Nov 15; 323(20):1361–6. doi:10.1056/NEJM199011153232001.
Синдром хронической усталости, миалгический энцефаломиелит и фибромиалгия
Aaron L. A., Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol. 2003 Aug;17(4):563–74. doi:10.1016/S1521-6942(03)00033-0. Baraniuk J. N., et al. A chronic fatigue syndrome — related proteome in human cerebrospinal fluid. BMC Neurol. 2005 Dec; 5:22. doi:10.1186/1471-2377-5-22.
Barnes P. R., et al. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 1993 Jun; 56(6):679–83. doi:10.1136/jnnp.56.6.679.
Bengtsson A., Henriksson K. G. The muscle in fibromyalgia — a review of Swedish studies. J Rheumatol Suppl. 1989 Nov; 19:144–9.
Brenu E. W., et al. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2011 May 28; 9:81. doi:10.1186/1479-5876-9-81.
Brown M. M., Jason L. A. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 2007 Jul 30;6:9. doi:10.1186/1476-5918-6-9.
Buchwald D., Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 1994 Sep 26; 154(18):2049–53. doi:10.1001/archinte.1994.00420180053007. Castro-Marrero J., et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013 Nov 20;19(15):1855–60. Epub Apr 22. doi:10.1089/ ars.2013.5346.
Cordero M. D., et al. Coenzyme Q(10): a novel therapeutic approach for fibromyalgia? case series with 5 patients. Mitochondrion. 2011 Jul; 11(4):623–5. doi:10.1016/j.mito.2011.03.122.
Cordero M. D., et al. Coenzyme Q10 in salivary cells correlate with blood cells in fibromyalgia: improvement in clinical and biochemical parameter after oral treatment. Clin Biochem. 2012 Apr; 45(6):509–11. doi:10.1016/j. clinbiochem.2012.02.001.
Cordero M. D., et al. Can coenzyme Q10 improve clinical and molecular parameter in fibromyalgia? Antioxid Redox Signal. 2013 Oct 20; 19(12):1356–61. Epub 2013 Mar 4. doi:10.1089/ars.2013.5260.
Cordero M. D., et al. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal. 2013 Mar 1;18(7):800–7. doi:10.1089/ars.2012.4892.
Devanur L. D., Kerr J. R. Chronic fatigue syndrome. J Clin Virol. 2006 Nov; 37(3):139–50. doi:10.1016/j.jcv.2006.08.013.
Exley C., et al. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses. 2009 Feb; 72(2):135–9. doi:10.1016/j.mehy.2008.09.040.
